Upload
nguyendat
View
217
Download
0
Embed Size (px)
Citation preview
© Heliae Technology Holdings, Inc. 2013 – Confidential 1
Algae: the next frontier in sustainable personal care products
Dr. Lee TonkovichVP of Research & DevelopmentMay 2014
© Heliae Technology Holdings, Inc. 2013 – Confidential
20 acre commercial site2 acre pilot / R&D
NutritionFresh Water
Energy Arable Land
Beverages
Food
Symbioscience
Petcare
Wrigley
Chocolate
Business
Rationale
Heliae – Who are we?Founder’s Rationale
2
Gilbert Arizona130 Associates
Heliae is a technology‐driven algae production company
© Heliae Technology Holdings, Inc. 2013 – Confidential
Algae: untapped opportunity
ANTIOXIDANTS
LIPIDS
3
Algae – versatile organism to convert sunlight into life’s building blocks for billions of years.
Nature utilizes the full value of algae…
Product opportunities are now emerging …PROTEINS
STARCHES
PIGMENTS
© Heliae Technology Holdings, Inc. 2013 – Confidential 4
Algae: Biological Diversity
Nature has provided > 100,000 species*
Genetic modification enables new products
Mutagenesis enhances lipid, pigments, products
Wild alga are found everywhere – soil, water, air
Vast product potential …
* M. Guiry, 2012, How many species of algae are there, J. Phycol, 48, 1057‐1063.
© Heliae Technology Holdings, Inc. 2013 – Confidential
Feed $103 Billion
Cosmetics & Personal Care $127 Billion
Functional Foods & Supplements $183 Billion
Fertilizers $171 Billion
Pharmaceuticals & Therapeutics
$880 Billion
Algae: Market Potential
5
SpecialtyChemicals
$750 Billion
Source: Multiple industry and market sources
© Heliae Technology Holdings, Inc. 2013 – Confidential 6
Heliae Two Year History in Personal Care
• Multiple ingredients: lipids, antioxidants, natural color
• Early stage joint development agreements with multinationals
• Strategic relationships
• Formulation of multiple SKU’s across a broad range of products
• Beauty from within, nutri-cosmetics
• Developing an algae based skin care and ingestible nutri-beauty brand for a 2015 launch
© Heliae Technology Holdings, Inc. 2013 – Confidential
Personal Care Ingredients
Chlorophyll
Phyocyanin
Phycoerythrin
Beta carotene
Astaxanthin
Lutein/Zeaxanthin
Pigments & Carotenoids for personal care –
enhanced by the sun in the Heliae Volaris process
© Heliae Technology Holdings, Inc. 2013 – Confidential
Omega 3 – EPA, DHA, ALAOmega 6Omega 7Omega 9
8
Lipids & Esters enhance personal care topical
and/or ingestible products
Personal Care Ingredients
© Heliae Technology Holdings, Inc. 2013 – Confidential
Ingredients - Astaxanthin
Astaxanthin Oleoresin Powerful natural antioxidant used in supplements for eye, bone/joint, and cardiovascular health
Haematococcus pluvialis
Haematococcus post‐extraction biomass high protein biomass with attractive amino acid profile; applications range from human food, animal feed, personal care in cosmetics
9
© Heliae Technology Holdings, Inc. 2013 – Confidential
Heliae formulating with leaders in Marine-based cosmetics
Heliae ingredients are included in products at prestigious spas
Personal Care Products
10
© Heliae Technology Holdings, Inc. 2013 – Confidential 11
Personal Care Products
• Heliae has made a large array of topical serums, scrubs, masks and lotions from whole algae, algae extracts, and algae based lipids
• We are developing nutri‐cosmetic formulas, combining ingestible and topical applications – including the addition of emerging strains for new ingredients
• Products align with the trend of strong naturalcolors in cosmetics
© Heliae Technology Holdings, Inc. 2013 – Confidential 12
Identify Strains
Deliver Products
Stage 0: Ideation for market / economics
Stage 1: Technical feasibility for economics
Stage 2: Product refinement /optimization
Stage 3: Pilot scale‐up / product samples
Stage 4: Pre‐commercial demo to commercial launch
How we work
© Heliae Technology Holdings, Inc. 2013 – Confidential
Stage‐Gate Process
Strain
Feasibility to Optimization
Pilot Scale‐up to Product Samples
Pre‐commercial Demo to Commercial Launch
How we work
13
© Heliae Technology Holdings, Inc. 2013 – Confidential 14
Delivering Products at Heliae
Development / Pilot facility• Developing new strains and
products• Derisk scale‐up & commercialization
First commercial production facility (2013)• GMP facility for Haematococcus• Delivering products to the market• Expansion planned
Second commercial facility construction (2015)• Capacity > 1000 tonnes/year• New strain and product line